Title : Comparison of the effects of hypolipidemic treatment on monocyte proinflammatory cytokine release in men and women with type 2 diabetes and atherogenic dyslipidemia.

Pub. Date : 2015

PMID : 26136131






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Simvastatin, fenofibrate, and simvastatin/fenofibrate combination therapy reduced monocyte release of TNF-alpha, inteleukin-1beta, interleukin-6, and MCP-1, with no difference between the treatment groups. Simvastatin C-C motif chemokine ligand 2 Homo sapiens
2 Simvastatin, fenofibrate, and simvastatin/fenofibrate combination therapy reduced monocyte release of TNF-alpha, inteleukin-1beta, interleukin-6, and MCP-1, with no difference between the treatment groups. Simvastatin C-C motif chemokine ligand 2 Homo sapiens
3 The effect of simvastatin/fenofibrate combination therapy on monocyte release of interleukin-6 and MCP-1 was more pronounced in the male population. Simvastatin C-C motif chemokine ligand 2 Homo sapiens